Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Elasmogen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014291
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical candidates that derived from VNARS (variable new-antigen receptors). Elasmogen’s anti-inflammatory programmes include ELN/21 and ELN/22. It plans to provide access of soloMER generation and NDure half-life extension platforms to other organizations in partnership for the novel development of their products. The company is a spin-off from the University of Aberdeen. Elasmogen is headquartered in Aberdeen, Scotland, the UK.

Elasmogen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Elasmogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Elasmogen Raises Funds through Equity Financing 10
Partnerships 11
Elasmogen, Feldan Bio Enter into Agreement with Amgen 11
Feldan Bio and Elasmogen Enter into Development Partnership 12
Elasmogen and Almac Discovery Enter into Co-Development Agreement 13
Equity Offering 14
Elasmogen Spin Off from University of Aberdeen 14
Elasmogen Ltd – Key Competitors 15
Elasmogen Ltd – Key Employees 16
Elasmogen Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Mar 16, 2017: Elasmogen Receives £1.2 M In Grant And Equity Investment 18
Product News 19
Jan 20, 2017: Elasmogen – shark proteins for drug discovery 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Elasmogen Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Elasmogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Elasmogen Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Elasmogen Raises Funds through Equity Financing 10
Elasmogen, Feldan Bio Enter into Agreement with Amgen 11
Feldan Bio and Elasmogen Enter into Development Partnership 12
Elasmogen and Almac Discovery Enter into Co-Development Agreement 13
Elasmogen Spin Off from University of Aberdeen 14
Elasmogen Ltd, Key Competitors 15
Elasmogen Ltd, Key Employees 16

★海外企業調査レポート[Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Institut Pasteur-製薬・医療分野:企業M&A・提携分析
    Summary Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology an …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • HanAll Biopharma Co Ltd (009420):製薬・医療:M&Aディール及び事業提携情報
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermat …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Hill-Rom Holdings Inc (HRC)-医療機器分野:企業M&A・提携分析
    Summary Hill-Rom Holdings Inc (Hill-Rom) is a medical technology company that offers patient support systems, surgical solutions and other front line care products. The company’s major products and services include patient care systems; safe mobility and handling solutions; non-invasive therapeutic …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Petrus Resources Ltd (PRQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrus Resources Ltd (Petrus Resources) is an energy company. The company operates in exploitation, strategic acquisitions, development, and risk-managed exploration of oil and gas properties in western Canada. It operates in the areas of Ferrier, Central Alberta, and the central Rocky Mount …
  • Summit Therapeutics Plc (SUMM):企業の財務・戦略的SWOT分析
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Kuwait Petroleum International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Petroleum International Ltd (KPI), a subsidiary of Kuwait Petroleum Corporation, is a downstream energy company. It carries out refining of crude oil, production and marketing of refined petroleum products. The company operates refinery in Milazzo, Italy, and has retail service statio …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • China National Petroleum Corporation-エネルギー分野:企業M&A・提携分析
    Summary China National Petroleum Corporation (CNPC) is an integrated oil and gas company that produces and supplies oil and gas and petrochemical products. The company explores, develops and produces hydrocarbons in onshore and offshore areas of China, Canada, Africa, Central Asia and Russia, Latin …
  • AECOM (ACM):電力:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • All in West! Capital Corporation:戦略・SWOT・企業財務分析
    All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Intesa Sanpaolo S.p.A:企業のM&A・事業提携・投資動向
    Intesa Sanpaolo S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intesa Sanpaolo S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Nichias Corp (5393):企業の財務・戦略的SWOT分析
    Nichias Corp (5393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • bioMerieux SA.:企業のM&A・事業提携・投資動向
    bioMerieux SA. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's bioMerieux SA. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, KP484 methylphenidate drug for the treatment of attention deficit hyperactivity diso …
  • Xeltis AG:医療機器:M&Aディール及び事業提携情報
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆